PMA

P120016: VASCADE VASCULAR CLOSURE SYSTEM

FDA PMA · Device, hemostasis, vascular · Cardiva Medical, Inc.

Key facts

PMA number P120016
Trade name VASCADE VASCULAR CLOSURE SYSTEM
Generic name Device, hemostasis, vascular
Applicant Cardiva Medical, Inc.
Owner/operator CARDIVA MEDICAL, INC.
Product code MGB
Approval date Jan 31, 2013
Docket number 13M-0592
Notice date May 17, 2013
Establishment registration 3011469355
FEI number 3011469355

At a glance

  • 10–99 Supplements
  • Sep 10, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals